raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:420728

Combined oxidative phosphorylation defect type 20

Synonyms: COXPD20

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

A rare mitochondrial oxidative phosphorylation disorder characterized by variable combination of psychomotor delay, hypotonia, muscle weakness, seizures, microcephaly, cardiomyopathy and mild dysmorphic facial features. Variable types of structural brain anomalies have also been reported. Biochemical studies typically show decreased activity of mitochondrial complexes (mainly complex I).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCombined oxidative phosphorylation defect type 20COXPD20
frDéficit combiné de la phosphorylation oxydative type 20= en
deKombinierter Defekt der oxidativen Phosphorylierung Typ 20= en
esDeficiencia combinada de la fosforilación oxidativa tipo 20= en
itDifetto combinato della fosforilazione ossidativa tipo 20= en
nlGecombineerde oxidatieve fosforylatiedeficiëntie type 20COXPD20 · Gecombineerde oxidatieve fosforyleringdeficiëntie type 20
ptDéfice combinado da fosforilação oxidativa tipo 20
plZłożony defekt fosforylacji oksydacyjnej typu 20= en
csKombinovaný deficit oxidativní fosforylace, typ 20= en
ukКомбінований дефект окисного фосфорилювання, тип 20= en
zh联合氧化磷酸化缺陷症20型= en
trKombine oksidatif fosforilasyon defekti tip 20= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615917Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.23NTBTattributedvalidated
MONDO0014397Evalidated
UMLSC4014660Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
VARS2Disease-causing germline mutation(s) inAssessedHGNC:21642ENSG000001374116128026p21.33valyl-tRNA synthetase 2, mitochondrial24827421[PMID]_25058219[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated24958846[PMID]_25058219[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_24958846[PMID]_25058219[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card